Brain Tumors

Oncology

8 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(4)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 & AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons (A10 and AS2-1)	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Antineoplastons A10 and AS2-1	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

Phase 2(1)

Drug	Company
methionine	GH Research PLC (GHRS)

Phase 1(2)

Drug	Company
mb-101	Fortress Biotech Inc. (FBIO)
mb-101	Fortress Biotech Inc. (FBIO)

BioSniper tracks 8 drugs in development for Brain Tumors across 4 companies.

There are 1 clinical trial targeting Brain Tumors tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.